IP Library Granted Patent US 7,569,386
Granted Patent B2
US 7,569,386 · App. 11/042,530 · Granted Aug 4, 2009

Chondroitin synthase gene and methods of making and using same

Assignee: The Board of Regents of the University of Oklahoma
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,569,386
App. No.
11/042,530
Granted
Aug 4, 2009
Kind
B2
Abstract

The present invention relates to a chondroitin synthase gene and methods of making and using same. In more particular, but not by way of limitation, the present invention relates to a chondroitin synthase gene from Pasteurella multocida and methods of isolating and using same. Additionally, the present invention relates to the use of unsulfated chondroitin and its preparation, as well as conversion into modified versions such as dermatan sulfate and chondroitin sulfate polymers.

Claims (18)

1. A purified nucleic acid segment having a coding region encoding enzymatically active chondroitin synthase, wherein the enzymatically active chondroitin synthase is a single protein that catalyzes the incorporation of both UDP-GlcA and UDP-GalNAc to form a chondroitin molecule, and wherein the purified nucleic acid segment comprises at least one of:

(a) the nucleotide sequence in accordance with SEQ ID NO:3; and

(b) a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:4.

2. A recombinant vector comprising the purified nucleic acid segment of claim 1 .

3. The recombinant vector of claim 2 , wherein the recombinant vector is selected from the group consisting of a plasmid, cosmid, phage, integrated cassette and virus vector.

4. The recombinant vector of claim 2 , further comprising a promoter operatively linked to the coding region encoding enzymatically active chondroitin synthase.

5. A recombinant host cell comprising the recombinant vector of claim 2 .

6. The recombinant host cell of claim 5 , wherein the host cell produces chondroitin.

7. The recombinant host cell of claim 5 , wherein the recombinant host cell is a prokaryotic cell.

8. The recombinant host cell of claim 5 , wherein the recombinant host cell is a eukaryotic cell cultured in vitro.

9. A purified nucleic acid segment having a coding region encoding enzymatically active chondroitin synthase, wherein the enzymatically active chondroitin synthase is a single protein that catalyzes the incorporation of both UDP-GlcA and UDP-GalNAc to form a chondroitin molecule, and wherein the purified nucleic acid segment has at least 90% identity to SEQ ID NO:3.

10. A recombinant vector comprising the purified nucleic acid segment of claim 9 .

11. The recombinant vector of claim 10 , wherein the recombinant vector is selected from the group consisting of a plasmid, cosmid, phage, integrated cassette and virus vector.

12. The recombinant vector of claim 10 , further comprising a promoter operatively linked to the coding region encoding enzymatically active chondroitin synthase.

13. A recombinant host cell comprising the recombinant vector of claim 10 .

14. The recombinant host cell of claim 13 , wherein the host cell produces chondroitin.

15. The recombinant host cell of claim 13 , wherein the recombinant host cell is a prokaryotic cell.

16. The recombinant host cell of claim 13 , wherein the recombinant host cell is a eukaryotic cell cultured in vitro.

Assignments (1)
CONFIRMATORY LICENSE Recorded Aug 5, 2010
From: UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 024792/0263 →
Continuity (6)
Continuation 0984248400 · Apr 25, 2001
Continuation 1104253000 · Jan 24, 2005
Continuation In Part 0928340200 · Apr 1, 1999
Continuation In Part 0943727700 · Nov 10, 1999
Provisional Application 6019953800 · Apr 25, 2000
Related Publication 20050164984A1 · Jul 28, 2005